Search

Your search keyword '"Benninga, M."' showing total 756 results
Start Over Author "Benninga, M."
756 results on '"Benninga, M."'

1. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case–control study

Author

Deianova, N., el Manouni el Hassani, S., Struijs, E. A., Jansen, E. E. W., Bakkali, A., van de Wiel, M. A., de Boode, W. P., Hulzebos, C. V., van Kaam, A. H., Kramer, B. W., d’Haens, E., Vijlbrief, D. C., van Weissenbruch, M. M., de Jonge, W. J., Benninga, M. A., Niemarkt, H. J., de Boer, N. K. H., and de Meij, T. G. J.

Published
2022
Full Text
View/download PDF

5. Coeliakie

Author

Schweizer, J. J., Wauters, E. A. K., Benninga, M. A., van Aalderen, W. M. C., de Blécourt, A C. E., Benninga, M. A., Didden, R., Elich, M., de Faber, J. T. H. N., de Graaf, E. A. B., Gringhuis, D., de Groot, I. J. M., Heineman-de Boer, J. A., Hendriks, J. J. E., Hendriks-Hofman, P. J., Jennekens-Schinkel, A., Kamphuis, R. P., Knoors, H., Last, B. F., Moonen, J. M. G., de Moor, J. M. H., Reeser, H. M., Schweizer, J. J., Siderius, E. J., Sinnema, G., Sprikkelman, A. B., Swanenburg de Veye, H. F. N., Wauters, E. A. K., Weber, J. W., and van Woudenberg, P. A.

Published
2010
Full Text
View/download PDF

10. P076 Abdominal pain severity for IBD in remission correlates with genetic clustering and enzymatic activity of faeces-derived Candida albicans strains

Author

Van Thiel, I, primary, Maasland, T, additional, van Wassenaer, E, additional, Hoekman, D, additional, Spooren, C, additional, Hakvoort, T, additional, Admiraal, I, additional, Theelen, B, additional, Levin, E, additional, Benninga, M, additional, Jonkers, D, additional, D'Haens, G, additional, Rosendahl, S, additional, Boekhout, T, additional, Hagen, F, additional, de Jonge, W, additional, and van den Wijngaard, R, additional

Published
2023
Full Text
View/download PDF

17. An ESPGHAN Position Paper on the Use of Low-FODMAP Diet in Pediatric Gastroenterology

Author

Thomassen, R A, Luque, V, Assa, A, Borrelli, O, Broekaert, I, Dolinsek, J, Martin-de-Carpi, J, Mas, E, Miele, E, Norsa, L, Ribes-Koninckx, C, Saccomani, M Deganello, Thomson, M, Tzivinikos, C, Verduci, E, Bronsky, J, Haiden, N, Köglmeier, J, de Koning, B, Benninga, M A, Pediatrics, Paediatric Gastroenterology, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction & Development (AR&D), Oslo University Hospital [Oslo], Universitat Rovira i Virgili, The Hebrew University of Jerusalem (HUJ), Great Ormond Street Hospital for Children [London] (GOSH), University Hospital of Cologne [Cologne], University of Maribor, University of Barcelona, Institut de Recherche en Santé Digestive (IRSD ), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Ecole Nationale Vétérinaire de Toulouse (ENVT), Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National Polytechnique (Toulouse) (Toulouse INP), Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), University of Naples Federico II = Università degli studi di Napoli Federico II, ASST Papa Giovanni XXIII [Bergamo, Italy], Hospital Universitari i Politècnic La Fe = University and Polytechnic Hospital La Fe, Inst Invest Sanitaria La FE, Sheffield Children's NHS Foundation Trust, Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), Università degli Studi di Milano = University of Milan (UNIMI), University Hospital Motol [Prague], Medizinische Universität Wien = Medical University of Vienna, Erasmus University Rotterdam, University of Amsterdam [Amsterdam] (UvA), SEGUIN, Nathalie, Thomassen, R A, Luque, V, Assa, A, Borrelli, O, Broekaert, I, Dolinsek, J, Martin-de-Carpi, J, Mas, E, Miele, E, Norsa, L, Ribes-Koninckx, C, Saccomani, M Deganello, Thomson, M, Tzivinikos, C, Verduci, E, Bronsky, J, Haiden, N, Köglmeier, J, de Koning, B, and Benninga, M A

Subjects
IRRITABLE-BOWEL-SYNDROME, Oligosaccharides, CHILDREN, Disaccharides, POLYOLS DIET, CLINICAL-TRIAL, Irritable Bowel Syndrome, Diet, Carbohydrate-Restricted, [SDV.MHEP.PED] Life Sciences [q-bio]/Human health and pathology/Pediatrics, QUALITY-OF-LIFE, MANAGEMENT, Humans, Settore MED/49 - Scienze Tecniche Dietetiche Applicate, REDUCES SYMPTOMS, Child, Settore MED/38 - Pediatria Generale e Specialistica, [SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatrics, [SDV.MHEP] Life Sciences [q-bio]/Human health and pathology, Monosaccharides, Gastroenterology, RANDOMIZED CONTROLLED-TRIAL, Diet, [SDV.AEN] Life Sciences [q-bio]/Food and Nutrition, Fermentation, Pediatrics, Perinatology and Child Health, LOW FERMENTABLE OLIGOSACCHARIDES, [SDV.AEN]Life Sciences [q-bio]/Food and Nutrition, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, CELIAC GLUTEN SENSITIVITY, Systematic Reviews as Topic
Abstract

OBJECTIVES: Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered. METHODS: Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. RESULTS: The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. CONCLUSIONS: There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present manuscript provides practical safety tips to be applied when the low-FODMAP diet is considered in children.

Published
2022
Full Text
View/download PDF

24. Association of training standards in pediatric gastroenterology, hepatology and nutrition in European training centers with formal national recognition of the subspecialty: a survey of the ESPGHAN National Societies Network 2016-2019

Author

Papadopoulou, A. Ribes-Koninckx, C. Baker, A. Noni, M. Koutri, E. Karagianni, M.-V. Protheroe, S. Guarino, A. Mas, E. Wilschanski, M. Roman, E. Escher, J. Furlano, R.I. Posovszky, C. Hoffman, I. Veres, G. Bronsky, J. Hauer, A.C. Tjesic-Drinkovic, D. Fotoulaki, M. Orel, R. Urbonas, V. Kansu, A. Georgieva, M. Thomson, M. Benninga, M. Thapar, N. Kelly, D. Koletzko, B. and Papadopoulou, A. Ribes-Koninckx, C. Baker, A. Noni, M. Koutri, E. Karagianni, M.-V. Protheroe, S. Guarino, A. Mas, E. Wilschanski, M. Roman, E. Escher, J. Furlano, R.I. Posovszky, C. Hoffman, I. Veres, G. Bronsky, J. Hauer, A.C. Tjesic-Drinkovic, D. Fotoulaki, M. Orel, R. Urbonas, V. Kansu, A. Georgieva, M. Thomson, M. Benninga, M. Thapar, N. Kelly, D. Koletzko, B.

Abstract

Background This survey evaluated the effects of the recognition of pediatric gastroenterology, hepatology and nutrition (PGHN) on European PGHN training centers. Method Standardized questionnaires were collected from training centers via the presidents/representatives of the National Societies Network of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition, from June 2016 to December 2019. Results A total of 100 training centers from 19 countries participated in the survey: 55 from 12 countries where PGHN is formally recognized (Group 1) and 45 from 7 countries where it is not (Group 2). Training centers in Group 2 were less likely to have an integrated endoscopy suite, a written training curriculum and a training lead (P=0.059, P<0.001 and P=0.012, respectively). Trainees in Group 2 were less likely to be exposed to an adequate number of diagnostic endoscopies, while no differences were found in relation to liver biopsies. Half of the training centers in both Groups do not have dedicated beds for PGHN patients, while in 64% and 58%, respectively, trainees do not participate in on-call programs for PGHN emergencies. Research training is mandatory in 26% of the centers. The duration of training, as well as the assessment and accreditation policies, vary between countries. Conclusions This study has revealed significant discrepancies and gaps in infrastructure and training programs, training leadership, and assessment of training and certification across European training centers in PGHN. Strategies to support the recognition of PGHN and to standardize and improve training conditions should be developed and implemented. An infographic is available for this article at: http://www.annalsgastro.gr/files/journals/1/ earlyview/2022/Infographic_AG-6496.pdf © 2022 Hellenic Society of Gastroenterology

Published
2022

25. An ESPGHAN position paper on the use of low-FODMAP diet in pediatric gastroenterology

Author

Thomassen, R. A., Luque, V, Assa, A., Borrelli, O., Broekaert, I, Dolinsek, J., Martin-de-Carpi, J., Mas, E., Miele, E., Norsa, L., Ribes-Koninckx, C., Saccomani, M. Deganello, Thomson, M., Tzivinikos, C., Verduci, E., Bronsky, J., Haiden, N., Koglmeier, J., de Koning, B., Benninga, M. A., Thomassen, R. A., Luque, V, Assa, A., Borrelli, O., Broekaert, I, Dolinsek, J., Martin-de-Carpi, J., Mas, E., Miele, E., Norsa, L., Ribes-Koninckx, C., Saccomani, M. Deganello, Thomson, M., Tzivinikos, C., Verduci, E., Bronsky, J., Haiden, N., Koglmeier, J., de Koning, B., and Benninga, M. A.

Abstract

Excluding oligo-, di-, monosaccharides and polyols (FODMAPs) from the diet is increasingly being used to treat children with gastrointestinal complaints. The aim of this position paper is to review the available evidence on the safety and efficacy of its use in children and provide expert guidance regarding practical aspects in case its use is considered . Members of the Gastroenterology Committee, the Nutrition Committee and the Allied Health Professionals Committee of the European Society for Pediatric Gastroenterology Hepatology and Nutrition contributed to this position paper. Clinical questions regarding initiation, introduction, duration, weaning, monitoring, professional guidance, safety and risks of the diet are addressed. A systematic literature search was performed from 2005 to May 2021 using PubMed, MEDLINE and Cochrane Database of Systematic Reviews. In the absence of evidence, recommendations reflect the expert opinion of the authors. The systematic literature search revealed that the low-FODMAP diet has not been comprehensively studied in children. Indications and contraindications of the use of the diet in different pediatric gastroenterological conditions are discussed and practical recommendations are formulated. There is scarce evidence to support the use of a low-FODMAP diet in children with Irritable Bowel Syndrome and no evidence to recommend its use in other gastrointestinal diseases and complaints in children. Awareness of how and when to use the diet is crucial, as a restrictive diet may impact nutritional adequacy and/or promote distorted eating in vulnerable subjects. The present article provides practical safety tips to be applied when the low-FODMAP diet is considered in children.

Published
2022

26. Fecal amine metabolite analysis before onset of severe necrotizing enterocolitis in preterm infants: a prospective case-control study

Author

MS Neonatologie, Child Health, Deianova, N, El Manouni El Hassani, S, Struijs, E A, Jansen, E E W, Bakkali, A, van de Wiel, M A, de Boode, Willem P, Hulzebos, C V, van Kaam, A H, Kramer, B W, d'Haens, E, Vijlbrief, D C, van Weissenbruch, M M, de Jonge, W J, Benninga, M A, Niemarkt, H J, de Boer, N K H, de Meij, T G J, MS Neonatologie, Child Health, Deianova, N, El Manouni El Hassani, S, Struijs, E A, Jansen, E E W, Bakkali, A, van de Wiel, M A, de Boode, Willem P, Hulzebos, C V, van Kaam, A H, Kramer, B W, d'Haens, E, Vijlbrief, D C, van Weissenbruch, M M, de Jonge, W J, Benninga, M A, Niemarkt, H J, de Boer, N K H, and de Meij, T G J

Published
2022

33. P711 Stool microbiome communities predict remission in pediatric Crohn’s disease patients even after start of treatment

Author

Verburgt, C, primary, Dunn, K A, additional, Bielawski, J P, additional, Otley, A R, additional, Heyman, M B, additional, Sunseri, W, additional, Shouval, D, additional, Levine, A, additional, de Meij, T, additional, Hyams, J S, additional, Denson, L A, additional, Kugathasan, S, additional, Benninga, M A, additional, de Jonge, W J, additional, and Van Limbergen, J E, additional

Published
2022
Full Text
View/download PDF

37. Chronic constipation in adults: Contemporary perspectives and clinical challenges. 1: Epidemiology, diagnosis, clinical associations, pathophysiology and investigation

Author

Scott, S M, Farmer, A D, Dinning, P G, Carrington, E V, Benninga, M A, Burgell, R E, Dimidi, E, Fikree, A, Ford, A C, Fox, M, Hoad, C L, Knowles, C H, Krogh, K, Nugent, K, Remes-Troche, J M, Whelan, K, and Corsetti, M

Subjects
chronic constipation, diagnosis, epidemiology, IBS-C, investigation, pathophysiology
Abstract

Chronic constipation is a prevalent disorder that affects patients’ quality of life and consumes resources in healthcare systems worldwide. In clinical practice, it is still considered a challenge as clinicians frequently are unsure as to which treatments to use and when. Over a decade ago, a Neurogastroenterology & Motility journal supplement devoted to the investigation and management of constipation was published (2009;21(Suppl.2)). This included seven articles, disseminating all themes covered during a preceding two-day meeting held in London, entitled ‘Current perspectives in chronic constipation: a scientific and clinical symposium’. In October 2018, the 3rd London Masterclass, entitled ‘Contemporary management of constipation’ was held, again over two days. All faculty members were invited to author two new review articles representing a collective synthesis of talks presented and discussions held during this meeting. PURPOSEThis article represents the first of these reviews, addressing epidemiology, diagnosis, clinical associations, pathophysiology and investigation. Clearly not all aspects of the condition can be covered in adequate detail; hence, there is a focus on particular ‘hot topics’ and themes that are of contemporary interest. The second review addresses management of chronic constipation, covering behavioural, conservative, medical and surgical therapies.

Published
2021

48. OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients

Author

Verburgt, C, primary, Dunn, K, additional, Bielawski, J, additional, Otley, A, additional, Heyman, M, additional, Sunseri, W, additional, Shouval, D, additional, Levine, A, additional, de Meij, T, additional, Hyams, J, additional, Denson, L, additional, Kugathasan, S, additional, Benninga, M, additional, de Jonge, W, additional, and Van Limbergen, J, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results